Hypoxia clinical trials

Explore recruiting hypoxia clinical trials.

Recruiting hypoxia studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Hypoxia trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Measuring Oncological Value of Exercise and Statin (MOVES)

Finland

Therapeutic confirmatory (Phase III) EU CTIS Study details

Desferal administration to improve the impaired reaction to hypoxia in diabetes (DESIRED) - A randomised, double-blind, placebo-controlled, cross-over study.

Sweden

Therapeutic exploratory (Phase II) EU CTIS Study details

Cerebral hemodynamic optimization by milrinone for the prevention of delayed cerebral ischemia in severe subarachnoid hemorrhage -OPTIMIL Study-

France

Therapeutic confirmatory (Phase III) EU CTIS Study details

Hypoxic ventilatory response (HVR): Effect of Esketamine

Netherlands

Therapeutic use (Phase IV) EU CTIS Study details

SYNERGY OSA - EFFICACY, SAFETY and TOLERABILITY OF COMBINED THERAPY WITH A SOMNOMED ORAL APPLIANCE AND THE CARBONIC ANHYDRASE INHIBITOR SULTHIAME IN PATIENTS WITH OBSTRUCTIVE SLEEP APNEA. A Randomized, Double-Blind, Placebo Controlled, Proof-of-Concept Trial

Denmark, Sweden

Therapeutic exploratory (Phase II) EU CTIS Study details

Duration of Surfactant administration and impact on Stabilisation of vital parameters in very preterm neonates: 1 minute versus 5 minutes – a prospective randomised-controlled phase IV trial

Austria

Therapeutic use (Phase IV) EU CTIS Study details

Hypoxia trials by city

Hypoxia in Toronto Hypoxia in Vancouver Hypoxia in Montreal Hypoxia in Calgary Hypoxia in Edmonton Hypoxia in Ottawa Hypoxia in Winnipeg Hypoxia in Quebec City Hypoxia in Hamilton Hypoxia in Kitchener Hypoxia in London Hypoxia in Halifax Hypoxia in New York Hypoxia in Los Angeles Hypoxia in Chicago Hypoxia in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease